Acetylsalicylic acid Active Not Recruiting Phase 4 Trials for Angioplasty, Transluminal, Percutaneous Coronary / Coronary Heart Disease (CHD) Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Active Not Recruiting | Treatment | 4 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT02939872 | Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events |